Workflow
Silence Therapeutics PLC(SLN) - 2020 Q4 - Earnings Call Transcript

Silence Therapeutics plc (NASDAQ:SLN) Q4 2020 Results Earnings Conference Call March 30, 2021 8:00 AM ET Company Participants Gem Hopkins - Head, Investor Relations and Corporate Communications Mark Rothera - President and CEO Craig Tooman - Chief Financial Officer Dr. Giles Campion - Head, R&D and CMO Conference Call Participants Julian Harrison - BTIG Patrick Trucchio - H.C. Wainwright Miles Dixon - Peel Hunt Myles Minter - William Blair Operator Good day, ladies and gentlemen. And welcome to the Silence ...